AeroLeads people directory · profile
Patrícia Coutinho De Souza, Dvm, Msc, Phd Email & Phone Number
Associate Principal Scientist and Associate Director (R4) - Molecular Pathology
at
Merck
1 work email found
@genmab.com
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Associate Principal Scientist and Associate Director (R4) - Molecular Pathology
Location
Princeton, New Jersey, United States
Who is Patrícia Coutinho De Souza, Dvm, Msc, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Patrícia Coutinho De Souza, Dvm, Msc, Phd is listed as Associate Principal Scientist and Associate Director (R4) - Molecular Pathology at Merck, based in Princeton, New Jersey, United States. AeroLeads shows a work email signal at genmab.com and a matched LinkedIn profile for Patrícia Coutinho De Souza, Dvm, Msc, Phd.
Patrícia Coutinho De Souza, Dvm, Msc, Phd previously worked as Associate Principal Scientist/Associate Director (R4) - Molecular Pathology at Merck and Senior Scientist - Pathology at Genmab. Patrícia Coutinho De Souza, Dvm, Msc, Phd holds Anatomic Pathology Residency/Phd Combined Program from Oklahoma State University.
Company email context
Email format at Merck
This section adds company-level context without repeating Patrícia Coutinho De Souza, Dvm, Msc, Phd's masked contact details.
*@genmab.com
68% confidence
AeroLeads found 1 current-domain work email signal for Patrícia Coutinho De Souza, Dvm, Msc, Phd. Compare company email patterns before reaching out.
Profile bio
About Patrícia Coutinho De Souza, Dvm, Msc, Phd
Patrícia Coutinho De Souza, Dvm, Msc, Phd is a Associate Principal Scientist and Associate Director (R4) - Molecular Pathology at Merck. She possess expertise in cancer research, preclinical imaging, lab animals, orthotopic tumor models, optical microscopy and 21 more skills.
Listed skills include Cancer Research, Preclinical Imaging, Lab Animals, Orthotopic Tumor Models, and 22 others.
Current workplace
Patrícia Coutinho De Souza, Dvm, Msc, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
6 roles
Patrícia Coutinho De Souza, Dvm, Msc, Phd work experience
A career timeline built from the work history available for this profile.
Associate Principal Scientist/Associate Director (R4) - Molecular Pathology
❈ Develop and validate tissue-based clinical assays (Singleplex/ Multiplex Immunohistochemistry/ Immunofluorescence/ In-Situ Hybridization) supporting Translational Molecular Biomarkers (TMB) across all therapeutic areas and clinical development phases.❈ Act as a subject matter expert in the development and validation of tissue-based assays, collaborating with project teams, biomarker leaders, clinical operations, and regulatory affairs to implement these assays in clinical trials.❈ Act as the assay lead responsible for the development and validation of immunohistochemistry and multiplex panels used in clinical trials, ensuring successful transfer of projects to CROs.❈ Collaborate with scientists and physicians in both early and late-stage clinical development to execute biomarker strategies in clinical trials.❈ Assist in the transition of biomarker assays from Discovery Research to Clinical Development by providing technical guidance on fit-for-purpose assay validation.❈ Serve as in-house expert representing Merck in interactions with CROs developing IHC, multiplex IF panels, and ISH assays to support our clinical biomarker programs.❈ Work closely with Data Sciences to develop and verify digital image analysis algorithms and results from image analysis projects.❈ Lab Manager (Molecular Pathology Team - Translational Molecular Biomarkers)
Senior Scientist - Pathology
❈ Characterizing immune activation and tumor proteins within various tumor types using Nanostring Digital Spatial Profiling (DSP) technology in collaboration with our Translational Medicine team and Genomics colleagues.❈ Working closely with our Digital Pathology group and amazing Data Scientists to develop computational solutions to analyze our H&E, IHC and multiplex immunofluorescence data.❈ Supporting to QC the H&E and IHC clinical stains in the GEN3009 (DuoHexaBody®- CD37)❈ Supporting to QC imaging data analysis generated in the NL and US Pathology labs. ❈ Responsible for developing the 7-color multiplex panel for the GEN1046 clinical samples. ❈ Responsible for developing the 5-color multiplex panel for the GEN3009 clinical samples.❈ Evaluating, qualitatively and quantitatively (H-Scores, % staining, etc.) a variety of immunohistochemical stains for target screening and biomarker assessment.❈ Working with external collaborators (eg David MacMillan's lab at the University of Princeton) to establish novel tissue-based assays for our Pathology team. ❈ Leading the collaboration between our US Pathology team and Verily (formerly Google Life Sciences) (San Francisco, CA).❈ Representative pathologist for some of our collaborations with Indica Labs.❈ Supporting Genmab's early and late stage portfolios by developing IHC and mIF protocols in our BOND RX slide stainer.❈ Managing the US Lab Pathology Interns (Summer 2021 and Summer 2022).❈ LabVantage LIMS super user at Genmab.❈ Leading the implementation of the LabVantage ELN for the Pathology US team.❈ Lab Head for the Pathology US team (Jan 2021 - Mar 2022).❈ Invited speaker at the “Oxford Global’s Tumour Microenvironment: In-Person Congress” November 1-2 2022, Berlin, Germany.
Apr 2020 - Jan 2023
Scientist I (Preclinical & Translational Development Team)
❈ Contributing to the design, execution and evaluation of in vivo studies supporting the Severe Genetic Disease and Immunotherapy teams, including the development of novel strategies for assessing the efficacy of treatment.❈ Serving as the pathology representative to the Stem Cell Research/Severe Genetic Disorders team at bluebird bio.❈ Directing in vivo studies employing novel cellular immunotherapy and gene therapy approaches from discovery to investigational new drug (IND)-enabling activities.❈ Improving our current multicolor fluorescence immunostaining protocols.❈ Expanding our digital pathology image analysis capabilities.❈ Developing new in vivo imaging modalities at bluebird bio.
Feb 2018 - Jan 2020
Postdoctoral Research Fellow (Harvard Medical School / Beth Israel Deaconess Medical Center)
Our research is focused on basic science and application development for hyperpolarized 13C magnetic resonance imaging. We are currently developing techniques for metabolic imaging of cancer that may yield new tools for diagnosis and treatment monitoring. ➤ Website: www.bidmc.org/mriresearchKeywords: Mouse model, rat model, in vivo preclinical research, preclinical & translational research, cancer research, kidney cancer, renal cell carcinoma, A498 cells, liver cancer, N1S1 cells, hepatocellular carcinoma, lung cancer, mammary adenocarcinoma, tumor microenvironment, tumor heterogeneity, anticancer therapy, treatment resistance, radiofrequency ablation (RFA), tumor perfusion, angiogenesis, bioluminescence imaging, hyperpolarized 13C MRI, hyperpolarized 13C pyruvate, metabolic imaging.
May 2015 - Feb 2018
Postdoctoral Research Fellow (Harvard Medical School / Beth Israel Deaconess Medical Center)
May 2015 - Feb 2018
4 education records
Patrícia Coutinho De Souza, Dvm, Msc, Phd education
Anatomic Pathology Residency/Phd Combined Program
Oklahoma State University
Masters Degree, School Of Veterinary Medicine And Animal Science, Experimental And Comparative Pathology Program
Usp - Universidade De São Paulo
Residency Training Program In Veterinary Anatomic Pathology
Universidade Federal De Minas Gerais
Doctor Of Veterinary Medicine (Dvm)
Universidade Federal De Viçosa
FAQ
Frequently asked questions about Patrícia Coutinho De Souza, Dvm, Msc, Phd
Quick answers generated from the profile data available on this page.
What company does Patrícia Coutinho De Souza, Dvm, Msc, Phd work for?
Patrícia Coutinho De Souza, Dvm, Msc, Phd works for Merck.
What is Patrícia Coutinho De Souza, Dvm, Msc, Phd's role at Merck?
Patrícia Coutinho De Souza, Dvm, Msc, Phd is listed as Associate Principal Scientist and Associate Director (R4) - Molecular Pathology at Merck.
What is Patrícia Coutinho De Souza, Dvm, Msc, Phd's email address?
AeroLeads has found 1 work email signal at @genmab.com for Patrícia Coutinho De Souza, Dvm, Msc, Phd at Merck.
Where is Patrícia Coutinho De Souza, Dvm, Msc, Phd based?
Patrícia Coutinho De Souza, Dvm, Msc, Phd is based in Princeton, New Jersey, United States while working with Merck.
What companies has Patrícia Coutinho De Souza, Dvm, Msc, Phd worked for?
Patrícia Coutinho De Souza, Dvm, Msc, Phd has worked for Merck, Genmab, Bluebird Bio, Beth Israel Deaconess Medical Center, and Harvard Medical School.
How can I contact Patrícia Coutinho De Souza, Dvm, Msc, Phd?
You can use AeroLeads to view verified contact signals for Patrícia Coutinho De Souza, Dvm, Msc, Phd at Merck, including work email, phone, and LinkedIn data when available.
What schools did Patrícia Coutinho De Souza, Dvm, Msc, Phd attend?
Patrícia Coutinho De Souza, Dvm, Msc, Phd holds Anatomic Pathology Residency/Phd Combined Program from Oklahoma State University.
What skills is Patrícia Coutinho De Souza, Dvm, Msc, Phd known for?
Patrícia Coutinho De Souza, Dvm, Msc, Phd is listed with skills including Cancer Research, Preclinical Imaging, Lab Animals, Orthotopic Tumor Models, Optical Microscopy, Bruker Mri Systems, C, and Veterinary Pathology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial